Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in Severe Preeclampsia
NCT04303806Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, randomised trial of rosuvastatin in preeclampsia (2 arms), sponsored by Assiut University. Primary endpoint: Effect of rosuvastatin on the clinical features of preeclampsia. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04303806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04303806.